Infantile Dilated Cardiomyopathy in Alström Syndrome
Author Information
Author(s): Muacevic Alexander, Adler John R, Van Huffel Julien, Derycke Emilien, Detaille Thierry, Moniotte Stéphane, Hubrechts Jelena
Primary Institution: University Hospital Saint-Luc, Brussels, BEL
Hypothesis
Can genetic testing for the ALMS1 gene improve the diagnosis and treatment of dilated cardiomyopathy in infants?
Conclusion
Early diagnosis of Alström syndrome can lead to improved quality of life and effective treatment for infants with dilated cardiomyopathy.
Supporting Evidence
- Both infants presented with severe dilated cardiomyopathy as the first sign of Alström syndrome.
- Genetic testing confirmed the diagnosis of Alström syndrome in both cases.
- One patient underwent successful surgical pulmonary artery banding, which improved her heart function.
Takeaway
This study talks about two babies with a rare disease that affects their hearts and other parts of their bodies. By testing their genes, doctors can find out what's wrong and help them feel better.
Methodology
The study presents two case reports of infants diagnosed with dilated cardiomyopathy and Alström syndrome, detailing their clinical assessments and treatments.
Limitations
The study is based on only two cases, which may not represent the broader population of patients with Alström syndrome.
Participant Demographics
Two infants, one Caucasian girl aged two months and one Asian girl aged five months.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website